Table 1 Risk for all-cause mortality, CVD and stroke incidence according to the dynamic MetS status.

From: Changes of metabolic syndrome status alter the risks of cardiovascular diseases, stroke and all cause mortality

Outcomes

Events, n(%)

OR(95% CI, P Value )

Model1

Model2

Model3

Death

 MetS-free

65 (42.8%)

Ref.

Ref.

Ref.

 MetS-recovery

26 (17.1%)

1.15 (0.72–1.83, p = .556)

1.11 (0.69–1.79, p = .660)

1.13 (0.70–1.83, p = .626)

 MetS-developed

21 (13.8%)

1.28 (0.78–2.12, p = .328)

1.36 (0.81–2.28, p = .250)

1.37 (0.81–2.32, p = .238)

 MetS-chronic

40 (26.3%)

0.92 (0.62–1.37, p = .683)

0.99 (0.65–1.50, p = .950)

0.96 (0.63–1.48, p = .863)

CVD

 MetS-free

119 (35.5%)

Ref.

Ref.

Ref.

 MetS-recovery

46 (13.7%)

1.11 (0.78–1.58, p = .552)

1.03 (0.73–1.47, p = .850)

1.04 (0.73–1.48, p = .849)

 MetS-developed

38 (11.4%)

1.28 (0.88–1.87, p = .203)

1.19 (0.81–1.74, p = .369)

1.24 (0.85–1.82, p = .272)

 MetS-chronic

132 (39.4%)

1.73 (1.34–2.24, p < .001)

1.54 (1.18-2.00, p = .001)

1.63 (1.25–2.13, p < .001)

Stroke

 MetS-free

60 (25.3%)

Ref.

Ref.

Ref.

 MetS-recovery

41 (17.3%)

2.01 (1.34–3.02, p < .001)

1.99 (1.32-3.00, p = .001)

2.08 (1.38–3.14, p < .001)

 MetS-developed

31 (13.1%)

2.10 (1.35–3.28, p = .001)

2.14 (1.37–3.35, p < .001)

2.22 (1.42–3.49, p < .001)

 MetS-chronic

105 (44.3%)

2.76 (1.99–3.81, p < .001)

2.81 (2.01–3.92, p < .001)

2.95 (2.11–4.15, p < .001)

  1. MetS, metabolic syndrome; OR, odd ratio; CI, confidence interval; CVD, cardiovascular diseases.
  2. Model1: unadjusted model.
  3. Model2: adjusted for age; sex.
  4. Model3: adjusted for age; sex; education; smoking status; alcohol consumption; work; marital status; residence; disease history.
Back to article page